Diosmetin (DIOS) is a flavone aglycone commonly occurring in citrus species and olive leaves, in addition it is one of the active ingredients of some medications. Based on both in vitro and in vivo studies several beneficial effects are attributed to DIOS but the biochemical background of its action seems to be complex and it has not been completely explored yet. Previous investigations suggest that most of the flavonoid aglycones have negative effect on ATP synthesis in a dose dependent manner. In our study 17 flavonoids were tested and interestingly DIOS caused a significant elevation of intracellular ATP levels after 6-and 12-h incubation in MDCK kidney cells. In order to understand the mechanism of action, intracellular ATP and protein levels, ATP/ADP ratio, cell viability and ROS levels were determined after DIOS treatment. In addition, impacts of different enzyme inhibitors and effect of DIOS on isolated rat liver mitochondria were also tested. Finally, the influence of DIOS on the ATP depleting effect of the mycotoxin, ochratoxin A was also investigated. Our major conclusions are the followings: DIOS increases intracellular ATP levels both in kidney and in liver cells. Inhibition of glycolysis or citric acid cycle does not decrease the observed effect. DIOS-induced elevation of ATP levels is completely abolished by the inhibition of ATP synthase. DIOS is able to completely reverse the ATP-depleting effect of the mycotoxin, ochratoxin A. Most probably the DIOS-induced impact on ATP system does not originate from the antioxidant property of DIOS. Based on our findings DIOS may be promising agent to positively influence ATP depletion caused by some metabolic poisons.
Introduction
Flavonoids are natural polyphenols with well-known antioxidant and scavenger characteristics [1] . Furthermore, flavonoids show cytoprotective effects and are considered to be promising agents in prevention and/or therapy of numerous disorders [1] [2] [3] [4] . Previous studies highlighted that besides their scavenger property flavonoids exerted influence on the activity of several enzymes, transporters and on cell signaling pathways [1] . Interestingly, based on our current knowledge all of the previous investigations suggested that at least some of the studied flavonoids were able to decrease intracellular ATP levels [5] [6] [7] [8] [9] . Chinnam et al. described the inhibition of Escherichia coli (E. coli) ATP synthase on purified F 1 subunit or membrane bound F 1 Fo complexes related to different dietary bioflavonoids [5] . Li et al. observed similar inhibitory effect of theaflavins on E. coli ATP synthase [6] : They suggested the F 1 part as the primary site of inhibition and they also reported the inhibition of electron transport chain. In another study, Kanno et al. found naringenin-induced significant decrease of intracellular ATP levels and increased dose-dependent hyperpolarization of mitochondrial membrane potential in HL-60 cells [7] . Moreover, Mathiesen et al. and Dorta et al. reported uncoupled oxidative phosphorylation due to C-methylated flavonoids [8] and substantial respiratory chain inhibition by quercetin and galangin [9] in rat liver mitochondria. In our literature survey we have not found any references observing that certain flavonoids might increase intracellular ATP levels.
Diosmetin (DIOS; Fig. 1 ) is a flavone aglycone occurring mainly in citrus species (and also in related products e.g. lemon or bergamot juices) and in olive (Olea europaea L.) leaves [10] [11] [12] [13] [14] . Furthermore, it is widely known that the glycoside of diosmetin called diosmin is the active ingredient of various vasoprotective medications, for example Detralex Ó or Daflon Ó (containing 450 mg diosmin) [15, 16] , which are capillary stabilizing agents. In addition, there have been described several other positive effects attributed to diosmin in recently published studies both in vitro and in vivo, indicating a complex mechanism of action [17] [18] [19] [20] [21] [22] . Previous pharmacokinetic investigations showed that only the aglycone DIOS can enter the bloodstream (no diosmin was detected in patent's blood plasma) [23, 24] . After administration of 450 mg oral dose of diosmin, about 1.0-1.5 lM peak concentrations of DIOS were reported in the plasma (studied in healthy human volunteers) [24] . The above listed facts support that additional investigations are needed to explore further potential biochemical effects of DIOS.
The mycotoxin, ochratoxin A (OTA) is a widely spread food contaminant [25, 26] . Principally nephrotoxic and carcinogenic effects are attributed to OTA but several other adverse effects are also assumed [27] . Previous studies suggested a multiple mechanism in the mode of action of OTA; however one of the most pronounced adverse impacts seems to be its very strong ATP depleting effect [27] . To our current knowledge there has not been reported any substance to be suitable to alleviate the negative effect of OTA on ATP synthesis.
In our present study 17 different flavonoid aglycones were examined from the flavone, flavonol, flavanone, flavanol and izoflavone molecular groups (Fig. 1) to explore their influence on intracellular ATP levels in MDCK kidney-derived cell line using primarily the luciferin-luciferase ATP dependent bioluminescent reaction. In agreement with the previous studies most of the applied flavonoids caused no or only a mild decrease of intracellular ATP concentrations [5] [6] [7] [8] [9] . In contrast, the flavone DIOS exerted a significant increase in ATP levels therefore, our experiments were focused on the investigation of this aglycone. In order to confirm our observation ATP/ADP ratios were also determined using HPLC-UV technique. Furthermore, different enzyme inhibitors were applied to get more information on the observed impact of DIOS; and the effect of DIOS on mitochondrial oxygen consumption was also tested using rat liver mitochondria. Finally, combined treatment of MDCK cells with OTA and DIOS was studied. Our results showed a considerable elevation of intracellular ATP levels after short (6-12 h) incubations with micromolar DIOS concentrations (5-15 lM) that fell to the control level after 24 h. Using the above described techniques we could not determine the exact mechanism of action of DIOS. Because of the very diverse biochemical effects of DIOS further extensive investigations should be performed. On the other hand, we could clearly show that DIOS was suitable to offset OTA-mediated ATP depletion and was even able to completely restore ATP levels in MDCK cells.
Materials and methods

Chemicals
All chemicals and reagents were of analytical grade. Diosmetin (DIOS), acacetin, hesperetin (from Extrasynthese), apigenin, chrysin, myricetin, quercetin (from Fluka), daidzein, luteolin (from Indofine), baicalein, catechin, fisetin, flavone, galangin, genistein, morin, naringenin, ochratoxin A (OTA), Dulbecco's Modified Eagle's Medium (DMEM) -high glucose (4500 mg/L), fetal bovine serum (FBS), oligomycin A (OmA), 3-bromopyruvic acid (3-BP), bovine serum albumin (BSA), adenosine 5 0 -triphosphate (ATP), adenosine diphosphate (ADP), penicillin/streptomicyn solution, trypsin solution, sodium dodecyl sulfate (SDS), Triton X 100 (all from Sig- ma-Aldrich), Bioluminescent ATP Assay Kit CLSII (from Roche), phenylmethylsulfonyl fluoride (PMSF) and fluorescamine (from Serva), calcein aceoxymethyl ester (CAM) and 6-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (C400; from Invitrogen) were used as received. 2000 lM flavonoid and 5000 lM OTA stock solutions were prepared in 96% ethanol (from Reanal, spectroscopic grade) and kept at 4°C protected from light.
Instrumentation
Hitachi F-4500 fluorescence spectrophotometer and Berthold Lumat LB9507 luminometer were used for fluorescent and luminescent experimentations. Measurements were done in the presence of air at room temperature. Promega GloMax Ò -Multi Microplate Multimode Reader was used for ROS-measurements.
Chromatographic analysis of ATP/ADP concentrations was performed on a Dionex Ultimate 3000 (Dionex Corp., Sunnyvale, CA, USA) analytical HPLC system composed of a binary gradient pump (HPG-3200SD), an autosampler (WPS-3000RS), a thermostatted column compartment (TCC-3000RS) and a UV/VIS multiple wavelength detector (MWD-3000RS). 
Bioluminescent ATP determination
Intracellular ATP concentrations were quantified using luciferin-luciferase bioluminescent reaction. Sample preparation, measurements and data analysis were done using the previously published method [28] without modifications applying internal standardization. After subjecting cells to the appropriate treatments, cells were washed twice with cold PBS (150 lL) thereafter 150 lL lysis buffer (0.2 M borate buffer, 10 mM MgSO 4 , 0.1% Triton X 100, pH 9.2) was added to the wells and the plates were kept at room temperature for 15 min. 50 lL cell lysates were pipetted into 75 ⁄ 12 mm disposable plastic cuvettes (Sarstedt) containing 100 lL luciferin-luciferase reagent and 850 lL ATP measuring buffer (0.1 M TRIS-acetate buffer, 10 mM MgSO 4 , 2 mM Na 2 EDTA, 0.1% Triton X 100, pH 7.75).
Determination of ATP/ADP ratio by HPLC-UV
To further verify our results a distinct ATP extraction method and instrumentation were also applied. First the medium was removed and cells were washed twice with 150 lL ice-cold PBS then 100 lL 10% cold (4°C) perchloric acid solution was added to the system. After incubation (5 min. on ice) every 80 lL extract was neutralized with 24 lL 20% KOH solution (with 1.5 M K 2 HPO 4 ) and incubated for 2 min. on ice. Then samples were centrifuged (4°C, 10 000 RPM, 5 min) to get rid of the resulting potassium perchlorate precipitate. 40 lL from the supernatant was injected to the instrument. The separation of ADP and ATP was carried out according to the method described by Kochanowski et al. [29] with some modifications. Buffer ''A'' was prepared by adding 8 mM of tetrabutylammonium bisulfate (Sigma-Aldrich) to 100 mM potassium phosphate (Spectrum 3D) buffer (pH 6.5), while buffer ''B'' was constructed using 70% buffer ''A'' and 30% methanol (Molar Chemicals). Both buffers were filtered on 0.2 lm filters (Merck) prior to use. Separation was carried out at 40°C on a Supelco Discovery C18 column (150 Â 4.6 mm, 5 lm particle size; Sigma-Aldrich) with a flow rate of 1 ml/min. The gradient profile was shortened compared to the method of Kochanowski et al. [29] according to the following description: from 0 to 5 min 100% ''A'', then from 5 to 20 min a linear raise of ''B'' to 77%, and from 20.5 to 28 min 100% ''A'' again to achieve column re-equilibration. All chromatograms were analyzed at 254 nm.
Determination of total protein concentrations with fluorescamine reagent
Our previously published method was used for total protein measurements without modifications [28] . Both ATP detection (lysis with Triton-borate buffer) and intracellular protein determination were performed from the same well. To prevent proteolysis the lysis buffer was completed with 0.2 mM PMSF. 75 lL lysates were added to 2000 lL borate buffer (0.2 M, pH 9.2) thereafter 50 lL fluorescamine solutions (10 mM; in DMSO) were vortexed into the samples. Fluorescence emission intensities were determined at 475 nm (k exc = 394 nm), then BSA-standardized total protein concentrations were calculated.
Calcein viability assay
Calcein acetoxymethyl ester (CAM) viability assays were performed based on our previously published method without modifications [28] . After two washing steps with 150 lL PBS cells were treated with 150 lL CAM solution/well (1.6 lM CAM in PBS) and incubated for 60 min at 37°C in the dark. Then the medium was removed and cells were washed twice with PBS. Thereafter 150 lL lysis buffer (0.1% SDS in PBS) was added to each well and incubated for 10 min at room temperature. 100 lL cell lysates were added to 2000 lL PBS then fluorescence emission intensities were determined (k exc = 480 nm, k em = 515 nm).
Investigation with enzyme inhibitors
In order to obtain more information on the mechanism of action of DIOS, enzyme inhibitors were applied: sodium fluoride (NaF) is a known inhibitor of enolase enzyme therefore it obstructs glycolysis, 3-bromopyruvic acid (3-BP) inhibits both hexokinase and pyruvate dehydrogenase enzymes [30, 31] , finally oligomycin A (OmA) inhibits the F O part of ATP synthase. Cells were treated with 10 lM DIOS in the absence and in the presence of different enzyme inhibitors for 12 h using the previously described conditions (Section 2.3.).
Isolation of rat liver mitochondria and determination of its oxygen consumption
Wistar rats were purchased from Charles River Hungary Breeding Ltd. The animals were kept under standardized conditions; tap water and rat chow were provided ad libitum. Animals were treated in compliance with approved institutional animal care guidelines. Rat liver mitochondria were prepared by the previously described standard protocol [32] . Liver was squeezed through a liver press. All isolated mitochondria were purified by Percoll gradient centrifugation [33] . Mitochondrial oxygen consumption was assessed by a Clark type oxygen microelectrode. The mitochondrial respiration was measured in the presence of different concentrations of DIOS applying the previously published protocol [34] . Results were assessed from the original registration curve.
Determination of intracellular ROS levels
Intracellular ROS levels were determined using the oxidationsensitive 6-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (C400) fluorescent dye. C400 is an acetylated fluorescein derivative; the non-fluorescent molecule is converted to fluorescent form by intracellular esterases and oxidation by ROS which occurs inside the cells [35, 36] . After subjecting cells to the appropriate treatment, cells were treated with 4 lM C400 for 2 h at 
Statistics
All experiments were repeated at least three times. Values are presented as means ± SD. Statistical analyses were performed with One-Way ANOVA using IBM SPSS Statistics software (Version 20). P < 0.05 was set as the level of significance.
Results and discussion
Effects of flavonoid aglycones on ATP levels of MDCK cells
First the effects of 17 different flavonoid aglycones were examined on intracellular ATP levels in MDCK cells applying 10 lM aglycone concentration and 12-h incubation time. Fig. 2a shows that among the tested flavonoids only DIOS caused significant elevation of ATP concentrations after 12-h treatment. Furthermore, minor (non-significant) increase of ATP was caused by apigenin. As Fig. 1 demonstrates there is some structural homology between DIOS and apigenin: both derivatives belong to the flavone molecular group (presence of 2,3-double bound and absence of 3-hydroxyl group) and possess the 5-and 7-hydroxyl groups. On the other hand, apigenin does not present the 3 0 -hydroxyl and 4 0 -methoxy substituent in ring B, but possesses the 4 0 -hydroxyl moiety. Interestingly, flavonoids possessing the 4 0 -O-methyl structure (e.g. acacetin) or more hydroxyl groups in ring B (e.g. luteolin) did not show the positive effect on ATP levels under the applied conditions. The other aglycones caused no significant effect or only mild decrease (fisetin and naringenin) of ATP levels during the 12-h incubation period (Fig. 2a) .
Thereafter, in a new series of experiments MDCK cells were treated again with 10 lM flavonoid concentration under the same conditions except that the incubation time in this case was 24 h. While acacetin, apigenin and diosmetin did not cause remarkable changes in ATP levels, other aglycones -with the exception of luteolin -resulted in a significant decrease of ATP/protein ratio compared to that of the control (Fig. 2b) . Baicalein, catechin, daidzein, flavone, galangin, genistein, hesperetin, morin, myricetin, naringenin and quercetin caused similar effect: about 25-30% reduction of ATP levels was observed. Chrysin resulted in lower (16%) while fisetin caused higher (46%) decrease of ATP than the above listed flavonoid aglycones. These results are in accordance with the previous investigations discussed in the introductory section [5] [6] [7] [8] [9] . Interestingly, after 24-h treatment a significant elevation (about 20%) of ATP levels was caused by luteolin. As it will be discussed also in the next part (Section 3.2.), the effect of DIOS is of short duration: in the case of 24-h treatment cellular ATP levels return to the control value. It is clearly seen in Fig. 1 that the only difference between DIOS and luteolin is the 4 0 -O-methyl moiety. Previous studies showed that DIOS can be metabolized to luteolin in liver cells both in vitro and in vivo, the demethylation is catalyzed by CYP1 isoenzymes [37, 38] . On the other hand, recent in vivo investigations highlighted that luteolin is a substrate of the catechol-O-methyl transferase (COMT) enzyme and interestingly the most preferable reaction is its 4 0 -O-methylation which results in the formation of DIOS [39, 40] . Since the activity of COMT enzyme in epithelial tubular kidney cells is high [41] and because luteolin did not increase ATP levels during 12-h treatment of MDCK kidney cells we hypothesize that the delayed (compared to DIOS) effect of luteolin on the ATP system is caused by the formation of its metabolic product DIOS.
Effects of flavone diosmetin on ATP levels and viability of MDCK cells
Based on the above described observations our attention was focused on flavone DIOS. To investigate the concentration and time dependence of the observed impact cells were treated with 5, 10 and 15 lM DIOS concentrations and ATP levels were determined after 6, 12 and 24-h incubations (Fig. 3) . After 6-h treatment, a dose dependent elevation of intracellular ATP/protein ratios was observed: Even 5 lM DIOS led to 16% increase and higher 
Effects of diosmetin on ATP levels and ATP/ADP ratios of MDCK cells (HPLC)
After quantification of intracellular ATP levels with luciferinluciferase reaction (using detergent ATP extraction method), in order to verify our results and to determine the ATP/ADP ratios, confirmatory measurements were performed with HPLC using perchloric acid for the extraction. MDCK cells were treated with 10 lM DIOS and after 12-h treatment ATP and ADP concentrations were quantified by HPLC-DAD system. Results are shown in Fig. 4 where determined ATP levels and ATP/ADP ratios of both the control and of the treated cells were expressed. These data are in good agreement with the results obtained from bioluminescent ATP determination: Significant increase of ATP concentration and considerable elevation of ATP/ADP ratio were observed.
Effects of flavone diosmetin on the ATP levels and viability of HepG2 cells
Thereafter to test the observed effect on a different cell line, additional measurements were performed using HepG2 liver cancer cells. Similarly to the MDCK cell line the elevation of ATP/protein ratios were detected after DIOS treatment. On the other hand it is important to note that a decrease of cell viability was also observed even in the case of lower DIOS concentrations based on total protein and calcein assays, suggesting a negative effect of DIOS on HepG2 cells. After 12-h incubation with 5-10 lM DIOS milder elevation of ATP/protein levels (8-11%, respectively) was observed. On the other hand, 7.5 and 10 lM DIOS caused a significant increase of ATP/protein ratios (18% and 32%, respectively) while considerable decrease of cell viability was also detected (15 and 20%, respectively) after 24-h treatment. Fig. 5 shows the determined values of ATP/protein ratio and calcein fluorescence after 24-h treatment with 5-10 lM DIOS. Total protein levels were in good correlation with calcein measurements (data not shown). There could be several explanations for the time difference of the DIOS-mediated effect between MDCK and HepG2 cells. Although the cell medium was the same, the uptake kinetics of DIOS to MDCK and HepG2 cells can be different and other tissue-derived differences can also play a role. Furthermore, it is possible that the metabolism of DIOS in HepG2 cells results in the delayed effect compared to MDCK cells. The decreased viability in HepG2 cells can be explained by the commonly occurring tumor selective toxicity of several flavonoids [42] [43] [44] , since MDCK is an immortalized, whereas HepG2 is a tumor cell line. This idea is supported by the study of Androutsopoulos et al. [45] where tumor selective negative effect of DIOS on cell cycle progression and cell proliferation were reported on breast cancer cells.
Effects of enzyme inhibitors on diosmetin-induced ATP elevation (MDCK cells)
In the next step of experiments different enzyme inhibitors were applied (using MDCK cells) in order to get more information on the observed DIOS-induced impact. Fig. 6 shows the measured ATP concentrations (applying bioluminescent ATP determination) after a 12-h combined treatment with DIOS and enzyme inhibitors. Our results show that negative effects of NaF (3 mM) and 3-BP (80 lM) concentrations on ATP levels were considerably compensated by the simultaneous treatment with 10 lM DIOS. These observations indicate that the inhibition of glycolysis or citric acid cycle cannot weaken or abolish the found impact. In contrast, complete inhibition of DIOS-induced increase of ATP production was caused by oligomycin A (15 lM) treatment (Fig. 6 ). These observations suggest that the positive effect of DIOS may be related directly or indirectly to the ATP synthase enzyme or to oxidative phosphorylation. 
Effects of diosmetin on mitochondrial oxygen consumption (isolated rat liver mitochondria)
To test the potential involvement of ATP synthase in the action of DIOS, its effect on rat liver mitochondria was also examined. Surprisingly, the oxygen consumption of isolated mitochondria did not show any increase after treatment with 5-15 lM DIOS. Only higher DIOS concentrations (20 lM or above) resulted in mild uncoupling effect (data not shown), which is exactly the opposite of what we expected. Because lower concentrations of DIOS (5-15 lM) did not increase the oxygen consumption of the isolated mitochondria we hypothesize that DIOS does not act directly on the ATP synthase enzyme. The indirect mechanism of DIOS could be resulted from several actions e.g. the modification of the gene expression or the modulation of different proteins. Since recent studies highlighted that flavonoids have diverse and very complex biochemical effects on living cells and organisms [1] [2] [3] [4] [17] [18] [19] [20] [21] [22] further extensive investigations are reasonable to conduct in order to decipher the exact mechanism of action of DIOS.
Diosmetin versus ATP depleting effect of ochratoxin A
Finally, the discovered positive impact of DIOS on the ATP system was tested in a model using a mycotoxin, ochratoxin A. The ATP depleting effect of OTA is not clearly understood yet but previous studies suggest its influence on the mitochondrial respiratory chain caused by the inhibition of mitochondrial phosphate transport and/or the direct effect on the electron transport chain (inhibition of succinate-supported electron activities) [27] . Based on our preliminary measurements on MDCK cells, low OTA concentrations (5-15 lM) cause major changes on ATP levels at least after 24-h treatment (data not shown). On the other hand, DIOS seems to be effective under shorter incubation times (6-12 h). Therefore MDCK cells were treated with 15 lM OTA (in 150 lL medium/well) and after 12-h incubation the system was supplemented/cotreated with 0-15 lM DIOS (in 50 lL DMEM/well, without the replacement of the previous 150 lL medium) and cells were incubated for further 12 h. Fig. 7 represents that under the applied conditions 15 lM OTA resulted in about 30% decrease of total protein-related ATP levels after the 24-h incubation period. Furthermore, all applied DIOS concentrations lead to significant elevation of ATP/protein values of OTA-exposed cells. The impact is so effective that 15 lM DIOS restore completely the intracellular ATP levels. Since ATP synthesis can be influenced by the oxidative status of the cells [46] antioxidant effect of DIOS was also tested applying the same conditions. 15 lM OTA caused an about 60% increase of ROS production (Fig. 8) . DIOS alone resulted in a mild reduction of ROS/total protein levels in MDCK cells. In addition, DIOS caused significant but not dramatic decrease of ROS/protein ratios in co-treated (both OTA and DIOS) cells compared to the simply OTA-exposed cells. In vitro antioxidant effect of DIOS was reported in previous studies [47, 48] . On the other hand, DIOS has much lower radical scavenging activity in cell cultures compared to other flavonoids (e.g. catechin, quercetin or luteolin) [48] [49] [50] . It is also supported by the study of Ramyaa and Padma [51] where OTA-induced oxidative stress was substantially alleviated by quercetin. However, none of the other tested flavonoids caused significant elevation of ATP levels in OTA-exposed cells (data not shown). These results suggest that the DIOS-induced effect on intracellular ATP concentrations is independent from or depends only slightly on the antioxidant property of the flavonoid. It is also important to note, that based on the previous studies the ATPdepleting effect of OTA is resulted from the inhibition of mitochondrial respiratory chain but its toxic effect is not related directly to the ATP synthase enzyme [27, [52] [53] [54] . On the other hand, DIOS abolished the negative effect of OTA on ATP system however, the inhibition of ATP synthase by olygomicin cannot be alleviated by DIOS. These observations also suggest the important role of ATP synthase in the action of DIOS but as we previously discussed the connection is probably indirect.
Conclusions
In our study the effects of flavonoids on cellular ATP levels were examined. We described for the first time the unexpected effect of DIOS on ATP levels. Our major conclusions are the following: DIOS Ã P < 0.05). DIOS alone caused milder decrease of ROS levels. However, 15 lM OTA resulted in about 60% increase of ROS/protein ratio. DIOS was able to slightly reduce the OTA-mediated elevated ROS production but the effect is not so strong, suggesting that antioxidative effect of DIOS does not play an important role in the observed effect on ATP system. [ctrl = control; OTA = ochratoxin A; DIOS = diosmetin].
increases intracellular ATP levels both in MDCK and HepG2 cells. Inhibition of glycolysis or citric acid cycle does not suppress the observed effect. DIOS-induced elevation of ATP levels is completely abolished by the inhibition of ATP synthase with oligomycin A. DIOS is able to reverse the ATP-depleting effect of the mycotoxin, ochratoxin A. Most probably the DIOS-induced impact on ATP system does not originate from to the antioxidant property of DIOS. Based on our findings the above described special impacts of DIOS may be suitable to positively influence ATP-depletion caused by some metabolic poisons.
